Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno C Medeiros

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Best Practice & Research. Clinical Haematology|November 24, 2018
Is there a standard of care for relapsed AML?Bruno C Medeiros
Leukemia Research|March 11, 2018
Interpretation of clinical endpoints in trials of acute myeloid leukemiaBruno C Medeiros
Blood|March 3, 2012
Unveiling the complexity of CK+ AMLBruno C Medeiros
Expert Review of Hematology|November 19, 2010
Plasma cell leukemia: concepts and managementMichaela Liedtke, Bruno C Medeiros
International Journal of Hematology|August 22, 2012
Novel agents in acute myeloid leukemiaAlexander Ungewickell, Bruno C Medeiros
Expert Opinion on Pharmacotherapy|September 15, 2015
Chemotherapy options for previously untreated acute myeloid leukemiaRyan C Lynch, Bruno C Medeiros
Expert Review of Hematology|April 19, 2011
Unfavorable-risk cytogenetics in acute myeloid leukemiaWan-Jen Hong, Bruno C Medeiros
Blood Reviews|February 19, 2018
Cardiovascular, pulmonary, and metabolic toxicities complicating tyrosine kinase inhibitor therapy in chronic myeloid leukemia: Strategies for monitoring, detecting, and managingBruno C Medeiros, Jennifer Possick, Michael Fradley
British Journal of Haematology|February 15, 2011
Acute myeloid leukaemia in the elderly: a reviewDaniel A Pollyea, Holbrook E Kohrt, Bruno C Medeiros
Leukemia & Lymphoma|February 7, 2013
A single-center experience of the nationwide daunorubicin shortage: substitution with doxorubicin in adult acute lymphoblastic leukemiaSamit Patel, Michaela Liedtke, Dat Ngo, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Best Practice & Research. Clinical Haematology|November 24, 2018
Is there a standard of care for relapsed AML?Bruno C Medeiros
Leukemia Research|March 11, 2018
Interpretation of clinical endpoints in trials of acute myeloid leukemiaBruno C Medeiros
Blood|March 3, 2012
Unveiling the complexity of CK+ AMLBruno C Medeiros
Expert Review of Hematology|November 19, 2010
Plasma cell leukemia: concepts and managementMichaela Liedtke, Bruno C Medeiros
International Journal of Hematology|August 22, 2012
Novel agents in acute myeloid leukemiaAlexander Ungewickell, Bruno C Medeiros
Expert Opinion on Pharmacotherapy|September 15, 2015
Chemotherapy options for previously untreated acute myeloid leukemiaRyan C Lynch, Bruno C Medeiros
Expert Review of Hematology|April 19, 2011
Unfavorable-risk cytogenetics in acute myeloid leukemiaWan-Jen Hong, Bruno C Medeiros
Blood Reviews|February 19, 2018
Cardiovascular, pulmonary, and metabolic toxicities complicating tyrosine kinase inhibitor therapy in chronic myeloid leukemia: Strategies for monitoring, detecting, and managingBruno C Medeiros, Jennifer Possick, Michael Fradley
British Journal of Haematology|February 15, 2011
Acute myeloid leukaemia in the elderly: a reviewDaniel A Pollyea, Holbrook E Kohrt, Bruno C Medeiros
Leukemia & Lymphoma|February 7, 2013
A single-center experience of the nationwide daunorubicin shortage: substitution with doxorubicin in adult acute lymphoblastic leukemiaSamit Patel, Michaela Liedtke, Dat Ngo, et al.
Pageof 11